Lol
I'd like to ask about the sales of this product at the next general meeting, lol.
The annual sales is 19.9 million, so it seems there are good demand for it.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux's seventh generic dossier accepted by FDA for review
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

Ann: Acrux's seventh generic dossier accepted by FDA for review, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $12.39K | 620.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 571000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 286349 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 571000 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 286349 | 2 |
0.021 | 80630 | 1 |
0.022 | 204574 | 4 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 11.30am 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online